Newswires

August 16, 2024 Reinsurance

"NORCAL Specialty Insurance Company","PNC QS","2024 06 30" Annual Statutory Statement

U.S. Markets via PUBT

STATEMENT AS OF JUNE 30, 2024 OF THE NORCAL Specialty Insurance Company

ASSETS

		Current Statement Date		4
	1	2	3	December 31

			Net Admitted Assets	Prior Year Net
	Assets	Nonadmitted Assets	(Cols. 1 - 2)	Admitted Assets
1. Bonds	53,514,715		53,514,715	51,010,043

Stocks:
1. Preferred stocks
2. Common stocks
Mortgage loans on real estate:
1. First liens
2. Other than first liens
Real estate:
1. Properties occupied by the company (less

	$	0	encumbrances)
	4.2 Properties held for the production of income
	(less $		0 encumbrances)
	4.3 Properties held for sale (less
	$	0	encumbrances)
5.	Cash ($	(78,341) ),
	cash equivalents ($		2,812,123	)
	and short-term investments ($	0	)	2,733,782	2,733,782	4,879,753
6.	Contract loans (including $		0	premium notes)

Derivatives
Other invested assets
Receivables for securities
Securities lending reinvested collateral assets
Aggregate write-ins for invested assets

12.	Subtotals, cash and invested assets (Lines 1 to 11)		56,248,497		56,248,497	55,889,796
13.	Title plants less $	0 charged off (for Title insurers
	only)
14.	Investment income due and accrued			313,019		313,019	350,072
15.	Premiums and considerations:
	15.1 Uncollected premiums and agents' balances in the course of
	collection			501,139	404,628	96,511
	15.2 Deferred premiums, agents' balances and installments booked but
	deferred and not yet due (including $		0 earned
	but unbilled premiums)			455,193		455,193	1,000,371
	15.3 Accrued retrospective premiums	($	346,970	) and
	contracts subject to redetermination ($	0 )	346,970	34,697	312,273	312,273
16.	Reinsurance:
	16.1 Amounts recoverable from reinsurers		8,314,943		8,314,943	5,802,591

Funds held by or deposited with reinsured companies
Other amounts receivable under reinsurance contracts

17. Amounts receivable relating to uninsured plans

18.1 Current federal and foreign income tax recoverable and interest thereon
18.2 Net deferred tax asset		240,936	15,575	225,361	298,230
19.	Guaranty funds receivable or on deposit
20.	Electronic data processing equipment and software
21.	Furniture and equipment, including health care delivery assets
	($	0 )
22.	Net adjustment in assets and liabilities due to foreign exchange rates
23.	Receivables from parent, subsidiaries and affiliates	2,356		2,356	507,761
24.	Health care ($	0 ) and other amounts receivable

Aggregate write-ins for other-than-invested assets
Total assets excluding Separate Accounts, Segregated Accounts and

	Protected Cell Accounts (Lines 12 to 25)	66,423,053	454,900	65,968,153	64,161,094
27.	From Separate Accounts, Segregated Accounts and Protected
	Cell Accounts
28.	Total (Lines 26 and 27)	66,423,053	454,900	65,968,153	64,161,094

DETAILS OF WRITE-INS

1101.

1102.

1103.

1198. Summary of remaining write-ins for Line 11 from overflow page

1199. Totals (Lines 1101 through 1103 plus 1198) (Line 11 above)

2501.

2502.

2503.

2598. Summary of remaining write-ins for Line 25 from overflow page

2599. Totals (Lines 2501 through 2503 plus 2598) (Line 25 above)

STATEMENT AS OF JUNE 30, 2024 OF THE NORCAL Specialty Insurance Company

LIABILITIES, SURPLUS AND OTHER FUNDS

					1	2
					Current	December 31,
					Statement Date	Prior Year
1.	Losses (current accident year $	0	)
2.	Reinsurance payable on paid losses and loss adjustment expenses
3.	Loss adjustment expenses				4,899,292	4,899,292
4.	Commissions payable, contingent commissions and other similar charges		7,375
5.	Other expenses (excluding taxes, licenses and fees)			134,526	150,349
6.	Taxes, licenses and fees (excluding federal and foreign income taxes)		83,396	83,396
7.1Current federal and foreign income taxes (including $	0	on realized capital gains (losses))	523,200	351,099
7.2 Net deferred tax liability
8.	Borrowed money $	0 and interest thereon $	0
9.	Unearned premiums (after deducting unearned premiums for ceded reinsurance of $	4,661,467 and
	including warranty reserves of $		0 and accrued accident and health experience rating refunds
	including $	0 for medical loss ratio rebate per the Public Health Service Act)
10.	Advance premium				250,445	241

11. Dividends declared and unpaid:

Stockholders
Policyholders

12. Ceded reinsurance premiums payable (net of ceding commissions)

2,616,564

2,435,709

Funds held by company under reinsurance treaties
Amounts withheld or retained by company for account of others
Remittances and items not allocated

16. Provision for reinsurance (including $

0 certified)

Net adjustments in assets and liabilities due to foreign exchange rates
Drafts outstanding

19.	Payable to parent, subsidiaries and affiliates	663,639	864,065
20.	Derivatives
21.	Payable for securities	350,000

Payable for securities lending
Liability for amounts held under uninsured plans

24.	Capital notes $	0 and interest thereon $	0
25.	Aggregate write-ins for liabilities
26.	Total liabilities excluding protected cell liabilities (Lines 1 through 25)	9,528,437	8,784,151
27.	Protected cell liabilities
28.	Total liabilities (Lines 26 and 27)		9,528,437	8,784,151
29.	Aggregate write-ins for special surplus funds
30.	Common capital stock		5,100,000	5,100,000

Preferred capital stock
Aggregate write-ins for other than special surplus funds
Surplus notes

34.	Gross paid in and contributed surplus			27,395,886	27,395,886
35.	Unassigned funds (surplus)				23,943,830	22,881,057
36.	Less treasury stock, at cost:
	36.1	0	shares common (value included in Line 30	$	0	)
	36.2	0	shares preferred (value included in Line 31	$	0	)
37.	Surplus as regards policyholders (Lines 29 to 35, less 36)				56,439,716	55,376,943
38.	Totals (Page 2, Line 28, Col. 3)			65,968,153	64,161,094

DETAILS OF WRITE-INS

2501.

2502.

2503.

2598. Summary of remaining write-ins for Line 25 from overflow page

2599. Totals (Lines 2501 through 2503 plus 2598) (Line 25 above)

2901.

2902.

2903.

2998. Summary of remaining write-ins for Line 29 from overflow page

2999. Totals (Lines 2901 through 2903 plus 2998) (Line 29 above)

3201.

3202.

3203.

3298. Summary of remaining write-ins for Line 32 from overflow page

3299. Totals (Lines 3201 through 3203 plus 3298) (Line 32 above)

STATEMENT AS OF JUNE 30, 2024 OF THE NORCAL Specialty Insurance Company

STATEMENT OF INCOME

					1	2	3
						Current Year	Prior Year	Prior Year Ended
						to Date	to Date	December 31
1.	Premiums earned:	UNDERWRITING INCOME

	1.1	Direct (written $	4,692,289	)	5,238,820	5,715,288	10,930,315
	1.2	Assumed (written $		0 )
	1.3	Ceded (written $	4,692,289	)	5,238,820	5,715,288	10,930,315
	1.4	Net (written $	0	)
2.		DEDUCTIONS:
Losses incurred (current accident year $	0 ):
	2.1 Direct			3,004,409	3,655,371	7,010,745
	2.2 Assumed
	2.3 Ceded			3,004,409	3,655,371	7,010,745
3.	2.4 Net
Loss adjustment expenses incurred		358,807	411,501	706,071
4.	Other underwriting expenses incurred		(357,290)	(536,126)	(831,049)
5.	Aggregate write-ins for underwriting deductions
6.	Total underwriting deductions (Lines 2 through 5)	1,517	(124,625)	(124,978)
7.	Net income of protected cells
8.	Net underwriting gain (loss) (Line 1 minus Line 6 + Line 7)	(1,517)	124,625	124,978
9.	Net investment income earned	INVESTMENT INCOME	1,027,335	818,594	1,775,623

10.	Net realized capital gains (losses) less capital gains tax of $	0
11.	Net investment gain (loss) (Lines 9 + 10)		1,027,335	818,594	1,775,623
12.			OTHER INCOME
Net gain or (loss) from agents' or premium balances charged off
13.	(amount recovered $	0	amount charged off $	0 )		(123,924)	(123,969)
Finance and service charges not included in premiums
14.	Aggregate write-ins for miscellaneous income		1,518	(701)	(1,010)
15.	Total other income (Lines 12 through 14)		1,518	(124,625)	(124,979)
16.	Net income before dividends to policyholders, after capital gains tax and before all other federal
	and foreign income taxes (Lines 8 + 11 + 15)	1,027,336	818,594	1,775,622

Dividends to policyholders
Net income, after dividends to policyholders, after capital gains tax and before all other federal

19.	and foreign income taxes (Line 16 minus Line 17)	1,027,336	818,594	1,775,622
Federal and foreign income taxes incurred	172,101	172,632	351,071
20.	Net income (Line 18 minus Line 19)(to Line 22)	855,235	645,962	1,424,551
21.	CAPITAL AND SURPLUS ACCOUNT
Surplus as regards policyholders, December 31 prior year	55,376,942	52,219,613	52,219,613
22.	Net income (from Line 20)	855,235	645,962	1,424,551

Net transfers (to) from Protected Cell accounts
Change in net unrealized capital gains or (losses) less capital gains tax of

25.	$	0	(14,850)	12,166	55,000
Change in net unrealized foreign exchange capital gain (loss)
26.	Change in net deferred income tax	(106,050)	(508,352)	(477,124)
27.	Change in nonadmitted assets	328,439	2,418,446	2,154,902

Change in provision for reinsurance
Change in surplus notes
Surplus (contributed to) withdrawn from protected cells
Cumulative effect of changes in accounting principles
Capital changes:
1. Paid in
2. Transferred from surplus (Stock Dividend)
3. Transferred to surplus
Surplus adjustments:
1. Paid in
2. Transferred to capital (Stock Dividend)
3. Transferred from capital
Net remittances from or (to) Home Office
Dividends to stockholders
Change in treasury stock
Aggregate write-ins for gains and losses in surplus

38.	Change in surplus as regards policyholders (Lines 22 through 37)	1,062,774	2,568,222	3,157,329
39.	Surplus as regards policyholders, as of statement date (Lines 21 plus 38)	56,439,716	54,787,835	55,376,942
0501.	DETAILS OF WRITE-INS

0502.
0503.
0598.	Summary of remaining write-ins for Line 5 from overflow page
0599.	TOTALS (Lines 0501 through 0503 plus 0598) (Line 5 above)
1401.	Miscellaneous (Expense) Income	1,518	(701)	(1,010)
1402.
1403.
1498.	Summary of remaining write-ins for Line 14 from overflow page
1499.	TOTALS (Lines 1401 through 1403 plus 1498) (Line 14 above)	1,518	(701)	(1,010)
3701.
3702.
3703.
3798.	Summary of remaining write-ins for Line 37 from overflow page
3799.	TOTALS (Lines 3701 through 3703 plus 3798) (Line 37 above)

STATEMENT AS OF JUNE 30, 2024 OF THE NORCAL Specialty Insurance Company

CASH FLOW

				1	2	3
				Current Year	Prior Year	Prior Year Ended
				To Date	To Date	December 31
1.		Cash from Operations
Premiums collected net of reinsurance		1,182,358	1,935,415	1,789,970
2.	Net investment income		936,644	853,420	1,839,590
3.	Miscellaneous income		1,518	(124,625)	(124,978)
4.	Total (Lines 1 to 3)		2,120,520	2,664,210	3,504,582
5.	Benefit and loss related payments		2,512,352	(3,022,417)	(3,463,648)
6.	Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts
7.	Commissions, expenses paid and aggregate write-ins for deductions		(287,635)	488,904	3,213,446
8.	Dividends paid to policyholders
9.	Federal and foreign income taxes paid (recovered) net of $	0 tax on capital
10.	gains (losses)				286,613
Total (Lines 5 through 9)		2,224,717	(2,533,513)	36,411
11.	Net cash from operations (Line 4 minus Line 10)		(104,197)	5,197,723	3,468,171
12.		Cash from Investments
Proceeds from investments sold, matured or repaid:
	12.1	Bonds		6,002,514	6,448,336	13,258,234
	12.2	Stocks
	12.3	Mortgage loans
	12.4	Real estate
	12.5	Other invested assets
	12.6	Net gains or (losses) on cash, cash equivalents and short-term investments
	12.7	Miscellaneous proceeds
13.	12.8	Total investment proceeds (Lines 12.1 to 12.7)		6,002,514	6,448,336	13,258,234
Cost of investments acquired (long-term only):
	13.1	Bonds		8,044,290	1,418,562	13,392,152
	13.2	Stocks
	13.3	Mortgage loans
	13.4	Real estate
	13.5	Other invested assets
	13.6	Miscellaneous applications
14.	13.7	Total investments acquired (Lines 13.1 to 13.6)		8,044,290	1,418,562	13,392,152
Net increase/(decrease) in contract loans and premium notes
15.	Net cash from investments (Line 12.8 minus Line 13.7 and Line 14)		(2,041,776)	5,029,774	(133,918)
16.		Cash from Financing and Miscellaneous Sources
Cash provided (applied):
	16.1	Surplus notes, capital notes
	16.2	Capital and paid in surplus, less treasury stock
	16.3	Borrowed funds
	16.4	Net deposits on deposit-type contracts and other insurance liabilities
	16.5	Dividends to stockholders
	16.6	Other cash provided (applied)			(2,542,022)
17.	Net cash from financing and miscellaneous sources (Line 16.1 through Line 16.4 minus Line 16.5
	plus Line 16.6)			(2,542,022)
18.		RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17)	(2,145,973)	7,685,475	3,334,253
19.	Cash, cash equivalents and short-term investments:
	19.1	Beginning of year		4,879,755	1,545,502	1,545,502
	19.2	End of period (Line 18 plus Line 19.1)		2,733,782	9,230,977	4,879,755

6WDWHPHQWDVRI-XQHRIWKH125&$/63(&,$/7<,1685$1&(&203$1<

127(672),1$1&,$/67$7(0(176

Note 1 - Summary of Significant Accounting Policies and Going Concern

Accounting practices
The accompanying financial statements of the NORCAL Specialty Insurance Company (NSIC or the Company) have been prepared on the basis of accounting practices prescribed or permitted by the Texas Insurance Department.
The Company was redomesticated to Texas effective April 25, 2018 as a domiciled surplus lines insurance company.
The Texas Department of Insurance requires insurance companies domiciled in the State to prepare statutory basis financial statements in accordance with the National Association of Insurance Commissioners Accounting Practices and Procedure manual (NAIC SAP). As of this reporting date, the Company does not use prescribed or permitted practices that affect net income, statutory surplus or risk based capital that differ from NAIC SAP. Certain prior year balances have been reclassified to conform to the current year presentation.

						Year-to-date period ended
		SSAP	F/S	F/S		June 30,	December 31,
		#	Page	Line #		2024		2023
NET INCOME
(1)	State basis (Page 4, Line 20, Columns 1 & 3)	XXX	XXX	XXX	$	855,235	$	1,424,551
(2)	State Prescribed Practices that are an increase/					-		-
(decrease) from NAIC SAP:
(3)	State Permitted Practices that are an increase/					-		-
(decrease) from NAIC SAP:
(4)	NAIC SAP (1-2-3=4)	XXX	XXX	XXX	$	855,235	$	1,424,551
SURPLUS

(5)	State basis (Page 3, Line 37, Columns 1 & 2)	XXX	XXX	XXX	$	56,439,716	$	55,376,943
(6)	State Prescribed Practices that are an increase/					-		-
(decrease) from NAIC SAP:
(7)	State Permitted Practices that are an increase/					-		-
(decrease) from NAIC SAP:
(8)	NAIC SAP (5-6-7=8)	XXX	XXX	XXX	$	56,439,716	$	55,376,943

The term "none" or "no significant change" is used in the following notes to indicate that the Company does not have any items requiring disclosure under the respective note.

Use of estimates in the preparation of the financial statements - No significant change.
Accounting policy
1. - (5) No significant change.

1. Loan-backedsecurities are reported at amortized cost provided that the SVO's designation is 1 or 2. If the SVO's designation is 3 or greater, the security is reported at the lower of amortized cost or fair value. The Company uses the prospective method to make valuation adjustments when necessary.
2. - (13) No significant change.
Going Concern
Based upon its evaluation of relevant conditions and events, including the 100% intercompany reinsurance with NORCAL Insurance Company, management does not have substantial doubt about the Company's ability to continue as a going concern.

Note 2 - Accounting Changes and Corrections of Errors- None.

Note 3 - Business Combinations and Goodwill- None.

Note 4 - Discontinued Operations- None.

6WDWHPHQWDVRI-XQHRIWKH125&$/63(&,$/7<,1685$1&(&203$1<

127(672),1$1&,$/67$7(0(176

Note 5 - Investments

Mortgage loans, including mezzanine real estate loans - None.
Debt restructuring - None.
Reverse mortgages - None.
Loan-backedsecurities
1. Prepayment assumptions for single-class and multi-classmortgage-backed/asset-backed securities were obtained from broker dealer survey values or internal estimates.
2. The Company has recognized no other-than-temporary impairments of loan-backed securities for intent to sell or for inability to hold to recovery as of June 30, 2024.
3. No loan-backed securities, held as of June 30, 2024, have incurred other-than-temporary impairments recognized in earnings based on the fact that the present value of projected cash flows expected to be collected was less than the amortized cost of the securities.
4. For all loan-backed securities held at June 30, 2024 for which fair value is less than cost, but which have had no other-than-temporary impairment recognized in earnings, the following table displays balances, according to duration of the loss position:

The aggregate amount of unrealized losses:

1.	Less than 12 Months	$	(46,191)
2.	12 Months or Longer	$	-

The aggregate related fair value of securities with unrealized losses:

1.	Less than 12 Months	$	12,270,438
2.	12 Months or Longer	$	-

1. The Company did not hold any loan-backed or structured securities that were in an unrealized loss position as of June 30, 2024.
Dollar repurchase agreements and/or securities lending transactions - None.
Repurchase agreements transactions accounted for as secured borrowing - None.
Reverse repurchase agreements transactions accounted for as secured borrowing - None.
Repurchase agreements transactions accounted for as a sale - None.
Reverse repurchase agreements transactions accounted for as a sale - None.
Real estate - None.
Low-incomehousing tax credits (LIHTC) - None.

6.1

6WDWHPHQWDVRI-XQHRIWKH125&$/63(&,$/7<,1685$1&(&203$1<

127(672),1$1&,$/67$7(0(176

Restricted assets
1. Restricted assets (including pledged)

				Gross (Admitted & Nonadmitted) Restricted						Current Year
					Current Year													Percentage
		1		2		3			4		5		6		7		8		9	10	11
				G/A		Total		Protected
							Cell												Admitted
		Total	Supporting	Protected			Account										Total	Gross
Restricted Asset		Protected		Cell			Assets					Increase/		Total		Restricted
	General		Cell	Account		Supporting		Total	Total From			Admitted	Restricted	to Total
Category		Account		Account	Restricted			G/A		(Decrease)	Nonadmitted	Restricted	to Total	Admitted
		(G/A)	Activity (a)		Assets		Activity (b)		(1 plus 3)	Prior Year	(5 minus 6)		Restricted	(5 minus 8)	Assets (c)	Assets (d)
a. Subject to contractual
obligation for which
liability is not shown	$	-	$	-	$	-		$	-	$	-	$	-	$	-	$	-	$	-	- %	- %
b. Collateral held under
security lending
agreements		-		-		-			-		-		-		-		-	$	-	- %	- %
c. Subject to repurchase
agreements		-		-		-			-		-		-		-		-	$	-	- %	- %
d. Subject to reverse
repurchase		-		-		-			-		-		-		-		-	$	-	- %	- %
agreements
e. Subject to dollar
repurchase		-		-		-			-		-		-		-		-	$	-	- %	- %
agreements
f. Subject to dollar
reverse repurchase		-		-		-			-		-		-		-		-	$	-	- %	- %
agreements
g. Placed under option
contracts		-		-		-			-		-		-		-		-	$	-	- %	- %
h. Letter stock or
securities restricted as
to sale - excluding
FHLB capital stock		-		-		-			-		-		-		-		-	$	-	- %	- %
i. FHLB capital stock		-		-		-			-		-		-		-		-	$	-	- %	- %
j. On deposit with states		2,746,645		-		-			-		2,746,645		5,253,794	(2,507,149)		-	$	2,746,645	4.1 %	4.2 %
k. On deposit with other
regulatory bodies		-		-		-			-		-		-		-		-	$	-	- %	- %
l. Pledged as collateral to
FHLB (including assets
backing funding
agreements)		-		-		-			-		-		-		-		-	$	-	- %	- %
m. Pledged as collateral
not captured in other
categories		-		-		-			-		-		-		-		-	$	-	- %	- %
n. Other restricted assets		-		-		-			-		-		-		-		-	$	-	- %	- %
o. Total Restricted Assets	$	2,746,645	$	-	$	-		$	-	$	2,746,645	$	5,253,794	$(2,507,149)	$	-	$	2,746,645	4.1 %	4.2 %

Subset of column 1
Subset of column 3
Column 5 divided by Asset Page, Column 1 Line 28
Column 9 divided by Asset Page, Column 3, Line 28
1. Detail of assets pledged as collateral not captured in other categories - None.
2. Detail of other restricted assets - None.
3. Collateral received and reflected as assets within the reporting entity's financial statements - None.

Working capital finance investments - None.
Offsetting and netting of assets and liabilities - None.
5GI Securities - None.
Short sales - None.
Prepayment penalty and acceleration fees - None.
Reporting entity's share of cash pool by asset type - None.

Note 6 - Joint Ventures, Partnerships and Limited Liability Companies

Detail for those greater than 10% of admitted assets - None.
Write-downsfor impairments - None.

6.2

6WDWHPHQWDVRI-XQHRIWKH125&$/63(&,$/7<,1685$1&(&203$1<

127(672),1$1&,$/67$7(0(176

Note 7 - Investment Income

Accrued investment income - None.
Amounts nonadmitted - None.
The gross, nonadmitted and admitted amounts for interest income due and accrued.

Interest Income Due and Accrued		Amount
1.	Gross	$	313,019
2.	Nonadmitted	$	-
3.	Admitted	$	313,019

The aggregate deferred interest - None.
The cumulative amounts of paid-in-kind (PIK) interest included in the current principal balance - None.

Note 8 - Derivative Instruments- None.

Note 9 - Income Taxes

A. The components of the net deferred tax asset/(liability) at June 30 are as follows:

1.	Change between years				6/30/2024					12/31/2023						Change
	by tax character		(1)		(2)		(3)		(4)		(5)		(6)		(7)		(8)		(9)
								(Col 1+2)						(Col 4+5)		(Col 1-4)		(Col 2-5)		(Col 7+8)
				Ordinary		Capital		Total		Ordinary		Capital		Total		Ordinary		Capital		Total
	(a)	Gross Deferred Tax Assets	$	305,560	$	10,467	$	316,027	$	380,959	$	7,348	$	388,307	$	(75,399)	$	3,119	$	(72,280)
	(b)	Statutory Valuation Allowance		-		10,467		10,467		-		7,348		7,348		-		3,119		3,119
		Adjustments
	(c)	Adjusted Gross Deferred Tax		305,560		-		305,560		380,959		-		380,959		(75,399)		-		(75,399)
		Assets (1a - 1b)
	(d)	Deferred Tax Assets		15,575		-		15,575		48,756		-		48,756		(33,181)		-		(33,181)
		Nonadmitted
	(e)	Subtotal Net Admitted		289,985		-		289,985		332,203		-		332,203		(42,218)		-		(42,218)
		Deferred Tax Asset (1c - 1d)
	(f)	Deferred Tax Liabilities		64,624		-		64,624		33,973		-		33,973		30,651		-		30,651
	(g)	Net Admitted Deferred Tax
		Asset/(Net Deferred Tax	$	225,361	$	-	$	225,361	$	298,230	$	-	$	298,230	$	(72,869)	$	-	$	(72,869)
		Liability)(1e-1f)
2.	Admission Calculation
			6/30/2024					12/31/2023						Change
	Components SSAP No. 101		(1)		(2)		(3)		(4)		(5)		(6)		(7)		(8)		(9)
								(Col 1+2)						(Col 4+5)		(Col 1-4)		(Col 2-5)		(Col 7+8)
				Ordinary		Capital		Total		Ordinary		Capital		Total		Ordinary		Capital		Total
	(a)	Federal Income Taxes Paid in
		Prior Years Recoverable
		Through Loss Carrybacks	$	172,101	$	-	$	172,101	$	-	$	-	$	-	$	172,101	$	-	$	172,101
	(b)	Adjusted Gross Deferred Tax
		Assets Expected To Be
		Realized (Lesser of 2(b)1 and
		2(b)2 Below)	$	53,260	$	-	$	53,260	$	298,229	$	-	$	298,229	$	(244,969)	$	-	$	(244,969)
		1. Adjusted Gross Deferred
		Tax Assets Expected To
		Be Realized Following the	$	53,260	$	-	$	53,260	$	298,229	$	-	$	298,229	$	(244,969)	$	-	$	(244,969)
		Balance Sheet Date

2. Adjusted Gross Deferred Tax Assets Allowed per

Limitation Threshold

XXX

XXX $ 8,428,058

XXX

XXX $ 8,261,807

XXX

XXX $ 166,251

Adjusted Gross Deferred Tax Assets Offset by Gross

Deferred Tax Liabilities

64,624

- $

64,624

33,973

- $

33,973

$ 30,651

- $ 30,651

Deferred Tax Assets Admitted as the result of application of

SSAP No. 101

$ 289,985

- $ 289,985

$ 332,202

- $ 332,202

$ (42,217)

- $ (42,217)

6.3

Attachments

Disclaimer

ProAssurance Corporation published this content on 16 August 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on August 16, 2024 at 14:57:24 UTC.

Older

The Federal Reserve and Pandora’s Box

Newer

"Preferred Physicians Medical RRG","PNC QS","2024 06 30" Annual Statutory Statement

Advisor News

More Advisor News

Annuity News

More Annuity News

Health/Employee Benefits News

More Health/Employee Benefits News

Life Insurance News

More Life Insurance News

"NORCAL Specialty Insurance Company","PNC QS","2024 06 30" Annual Statutory Statement

Advisor News

Annuity News

Health/Employee Benefits News

Life Insurance News

Sign in with your Insider Pro Account